Superior overall survival with blinatumomab versus chemotherapy as pre-transplant consolidation treatment in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia (B-ALL): longer follow-up (FU) of a Phase 3 randomized controlled trial (RCT)
Focatelli, F. Zugmaier, G. Rizzari, C. Dorris, J. D. Gruhn, B. Klingebie, T. Parasole, R. Linderkamp, C. Flotho, C. Petit, A.
Focatelli, F.
Zugmaier, G.
Rizzari, C.
Dorris, J. D.
Gruhn, B.
Klingebie, T.
Parasole, R.
Linderkamp, C.
Flotho, C.
Petit, A.
Citations
Altmetric:
Abstract
Affiliation
Department of Hematology/Oncology and Cell and Gene Therapy, Bambino Gesù Children's Hospital, Sapienza, University of Rome, Rome
Description
Date
2021
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Focatelli F, Zugmaier G, Rizzari C, Dorris JD, Gruhn B, Klingebie T, et al. Superior Overall Survival with Blinatumomab Versus Chemotherapy As Pre-Transplant Consolidation Treatment in Children with High-Risk First-Relapse B-Cell Precursor Acute Lymphoblastic Leukemia (B-ALL): Longer Follow-up (FU) of a Phase 3 Randomized Controlled Trial (RCT). Blood. 2021 Nov;138. PubMed PMID: WOS:000736398804255.